EUVIMEDEUVIMED entdecken
Crossref

Frequency and determinants of serum calcium monitoring during eldecalcitol therapy in patients with osteoporosis

Kairi Ri, Toshiki Fukasawa, Soichiro Masuda, Shiro Tanaka, Masato Takeuchi, Satomi Yoshida, Koji Kawakami

Journal of Bone and Mineral Metabolism · 2023-11 · 41 (6) · 890-900

DOI: 10.1007/s00774-023-01470-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Bone and Mineral Metabolism, online erschienen am 28.10.2023. Verfasst von Kairi Ri und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan. Hauptthemen laut MEDLINE: Hypercalcemia, Osteoporosis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Eldecalcitol (ELD) is an active vitamin D3 analog (AVD) commonly used to treat osteoporosis in Japan. Although routine monitoring of serum calcium levels during ELD therapy is recommended, little is known about the actual frequency and determinants of monitoring. MATERIALS AND METHODS: This was a descriptive cohort study using a Japanese electronic medical records database. We identified osteoporosis patients who initiated treatment with ELD or other AVDs (alfacalcidol and calcitriol) between April 1, 2011 and September 10, 2021. The index date for cohort entry was the first prescription date of ELD or other AVDs. The frequency of serum calcium monitoring was evaluated every 6 months. Determinants of serum calcium monitoring were identified using multivariable logistic regression models. We also calculated the incidence of hypercalcemia and the frequency of serum calcium monitoring within 6 months before hypercalcemia. RESULTS: We identified 12,671 ELD users and 7867 other AVD users. Within 6 months after cohort entry, 45.9% of ELD users and 58.7% of other AVD users underwent serum calcium monitoring. Female sex, no use of systemic corticosteroids, moderate-to-good renal function, treatment in smaller hospitals, and treatment in orthopedic surgery departments were associated with a lower likelihood of receiving serum calcium monitoring during ELD therapy. The incidence of hypercalcemia among ELD users was 6.36 per 100 person-years, with 20.6% of cases not receiving serum calcium monitoring before hypercalcemia. CONCLUSION: Our findings suggest that serum calcium monitoring is not given adequate attention during ELD therapy in routine clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypercalcemiaOsteoporosisHumansFemaleCalciumCohort StudiesBone DensityVitamin D

Stichwörter der Autor:innen

EldecalcitolHypercalcemiaMonitoringOsteoporosisVitamin D

Substanzen

eldecalcitolCalciumVitamin D

Autor:innen und Institutionen

  • Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan.
  • Department of Digital Health and Epidemiology, Graduate School of Medicine and Public Health, Kyoto University, Yoshidakonoe-Cho, Sakyo-Ku, Kyoto, 606-8501, Japan.
  • Department of Orthopaedic Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Department of Clinical Biostatistics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan. yoshida.satomi.4r@kyoto-u.ac.jp.

Zitieren

APA

Ri, K., Fukasawa, T., Masuda, S., Tanaka, S., Takeuchi, M., Yoshida, S., & Kawakami, K. (2023). Frequency and determinants of serum calcium monitoring during eldecalcitol therapy in patients with osteoporosis. Journal of Bone and Mineral Metabolism, 41(6), 890-900. https://doi.org/10.1007/s00774-023-01470-7

Vancouver

Ri K, Fukasawa T, Masuda S, Tanaka S, Takeuchi M, Yoshida S, et al. Frequency and determinants of serum calcium monitoring during eldecalcitol therapy in patients with osteoporosis. Journal of Bone and Mineral Metabolism. 2023;41(6):890-900. doi:10.1007/s00774-023-01470-7

BibTeX
@article{Ri2023,
  author = {Ri, Kairi and Fukasawa, Toshiki and Masuda, Soichiro and Tanaka, Shiro and Takeuchi, Masato and Yoshida, Satomi and Kawakami, Koji},
  title = {Frequency and determinants of serum calcium monitoring during eldecalcitol therapy in patients with osteoporosis},
  journal = {Journal of Bone and Mineral Metabolism},
  year = {2023},
  volume = {41},
  number = {6},
  pages = {890--900},
  doi = {10.1007/s00774-023-01470-7}
}
Kostenlos starten →